2015-2019 Global Diabetic Retinopathy Market Size, Growth, Trends, Analysis, Challenge, Vendor Landscape, Report
Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease. Laser surgery, injection of corticosteroids or anti-VEGF drugs into the eye, and vitrectomy are some of the available treatments. One feature of diabetic retinopathy is diabetic macular edema. This is a serious medical condition involving leakage of fluid from the minute, delicate, and previously injured blood vessels located at the back of the eye, which then collects in the macula. This results in inflammation of tissue and blurry vision. Get Full Details On: http://www.researchbeam.com/global-diabetic-retinopathy-2015-2019-market
Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease. Laser surgery, injection of corticosteroids or anti-VEGF drugs into the eye, and vitrectomy are some of the available treatments. One feature of diabetic retinopathy is diabetic macular edema. This is a serious medical condition involving leakage of fluid from the minute, delicate, and previously injured blood vessels located at the back of the eye, which then collects in the macula. This results in inflammation of tissue and blurry vision.
Get Full Details On:
http://www.researchbeam.com/global-diabetic-retinopathy-2015-2019-market
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Report</strong> Overview<br />
<strong>Global</strong> <strong>Diabetic</strong> <strong>Retinopathy</strong> <strong>Market</strong> <strong>2015</strong>-<strong>2019</strong>, has been prepared based on an in-depth<br />
market analysis with inputs from industry experts. The report covers the Americas, EMEA, and<br />
APAC; it also covers the global diabetic retinopathy market landscape and its growth prospects<br />
in the coming years. The report also includes a discussion of the key vendors operating in this<br />
market.<br />
Key Regions<br />
• Americas<br />
• APAC<br />
• EMEA<br />
Key <strong>Vendor</strong>s<br />
• Bayer<br />
• F. Hoffmann-La Roche<br />
• Novartis<br />
• Regeneron Pharmaceuticals
Change language